Durbin is the market leading provider of Expanded Access programs to the biopharmaceutical industry. Through partnering with Industry, Durbin is reimagining the role that Expanded Access Programs play in supporting healthcare practitioners and patients access lifechanging treatments, when they require them, no matter where they are in the world. Durbin’s operational and regulatory knowhow, experience across multiple speciality therapeutic areas and expertise in managing complex formulations including cell and gene therapies, ensures that every program is tailored to the specific needs of the treatment, patient and local market requirements.

Contact Uniphar Durbin Global
Visit Website